发明名称 IMMUNOGENIC COMPOSITION
摘要 The present invention relates to fusion proteins comprising fragments from toxin A and/or toxin B of Clostridium difficile, in particular the invention relates to proteins comprising a first fragment and a second fragment, wherein (v) the first fragment is a toxin A repeating domain fragment; (vi) the second fragment is a toxin B repeating domain fragment; (vii) the first fragment has a first proximal end; (viii) the second fragment has a second proximal end; and wherein the first fragment and the second fragment are adjacent to one another and wherein the polypeptide elicits antibodies that neutralize toxin A or toxin B or both. The invention further relates to compositions comprising fragments or variants of SEQ ID NO:1 0, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19, SEQ ID NO:28, SEQ ID NO:29, SEQ ID NO:30, SEQ ID NO:31, SEQ ID NO:32, SEQ ID NO:33 or SEQ ID NO:34 or SEQ ID NO:35.
申请公布号 AU2016203241(A1) 申请公布日期 2016.07.14
申请号 AU20160203241 申请日期 2016.05.18
申请人 GLAXOSMITHKLINE BIOLOGICALS S.A. 发明人 CASTADO, CINDY
分类号 C12N15/62;A61K39/08;C07K14/33 主分类号 C12N15/62
代理机构 代理人
主权项
地址